Home    中文  
 
  • Search
  • lucene Search
  • Citation
  • Fig/Tab
  • Adv Search
Just Accepted  |  Current Issue  |  Archive  |  Featured Articles  |  Most Read  |  Most Download  |  Most Cited

Chinese Journal of Breast Disease(Electronic Edition) ›› 2008, Vol. 02 ›› Issue (02): 28-31. doi: 10.3877/cma.j.issn.1674-0807.2008.02.008

• Experimental Research • Previous Articles     Next Articles

Expressions of matrix metalloproteinase-2 and sialyl Lewis-X in breast carcinoma and the significance

Peizhong SHANG1, ZHANG Jin-jiang ,1, Guo-hong JIA1, Yong-qing LI1, Jian-jun MIAO1, Xiao-wu LI1, Hua-ping GU1   

  1. 1.Department of General Surgery,The 251th Hospital of PLA, Zhangjiakou 075000, China
  • Online:2008-04-01 Published:2024-12-06

Abstract:

Objective

To investigate the expressions of matrix metalloproteinase-2 (MMP-2) and sialyl Lewis-X(SLeX) in breast carcinoma and their relationships with lymph node metastasis and prognosis.

Methods

The expressions of MMP-2 and SLeX in breast carcinoma (n =120 cases),metastatic lymph nodes (n =71 cases) and normal epithelial tissue remote from carcinoma (n =30 cases) were studied with microwave-labelled streptavidin biotin immunohistochemical method.

Results

The positive rates of MMP-2 and SLeX expressions were 16.7% (5/30) and 20.0% (6/30)in normal breast tissue,and 78.3%(94/120) and 86.7% (104/120) in breast carcinoma,respectively. The expressions of MMP-2 and SLeX in breast carcinoma were significantly higher than in the normal breast tissues (P <0.05). There was no difference in MMP-2 expression in the primary of breast carcinoma between patients with lymphaden metastasis and patients without lymphaden metastasis(P >0.05). The positive rate of SLeX in the primary breast carcinoma with lymphaden metastasis was higher than that without lymphaden metastasis(P <0.05). The positive rates of MMP-2 and SLeX expressions were 21. 1% (15/71) and 88. 7%(63/71) in metastatic lymph nodes, respectively. The expression of SLeX in metastatic lymph nodes was corresponding to that in the primary of breast carcinoma (r =0.874,P <0.05).

Conclusion

MMP-2 and SLeX were both highly expressed in breast carcinoma. SLeX was closely related to lymphaden metastasis. MMP-2 and SLeX,as a tumor-associated antigen in breast carcinoma, can be used as important markers to predict invasion, metastasis and prognosis.

Key words: Breast carcinoma, Matrix metalloproteinase-2, Sialyl Lewis-X, Infiltration; Metastasis

京ICP 备07035254号-13
Copyright © Chinese Journal of Breast Disease(Electronic Edition), All Rights Reserved.
Tel: 0086-10-51322630 E-mail: jcbd@medmail.com.cn
Powered by Beijing Magtech Co. Ltd